| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
501,201 |
350,864 |
$14.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
47,955 |
41,141 |
$8.88M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
16,484 |
12,080 |
$8.64M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
36,278 |
23,382 |
$7.90M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
18,745 |
15,833 |
$5.53M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13,722 |
9,663 |
$5.39M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
41,834 |
36,641 |
$5.24M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
11,722 |
9,975 |
$3.49M |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,765 |
11,543 |
$2.93M |
| G0378 |
Hospital observation service, per hour |
18,308 |
13,334 |
$2.80M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
69,456 |
52,772 |
$2.78M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
69,576 |
29,866 |
$2.71M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
6,080 |
4,631 |
$2.69M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
6,548 |
4,882 |
$2.34M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
43,093 |
27,618 |
$2.21M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
31,569 |
14,219 |
$2.10M |
| 59025 |
Fetal non-stress test |
9,383 |
4,901 |
$1.96M |
| 20610 |
|
13,455 |
8,556 |
$1.90M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
5,028 |
4,451 |
$1.75M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
2,268 |
1,855 |
$1.74M |
| 74178 |
|
2,861 |
2,078 |
$1.69M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
6,927 |
4,965 |
$1.69M |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
4,888 |
4,368 |
$1.67M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
19,320 |
17,325 |
$1.66M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
57,321 |
45,755 |
$1.56M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
3,848 |
2,770 |
$1.55M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
42,619 |
23,323 |
$1.46M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
42,960 |
23,524 |
$1.40M |
| 80053 |
Comprehensive metabolic panel |
115,210 |
84,206 |
$1.37M |
| 71045 |
Radiologic examination, chest; single view |
40,253 |
26,417 |
$1.36M |
| 36415 |
Collection of venous blood by venipuncture |
349,059 |
162,192 |
$1.31M |
| 96376 |
|
26,855 |
9,561 |
$1.30M |
| 72131 |
|
6,347 |
5,069 |
$1.30M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,094 |
11,632 |
$1.27M |
| 47562 |
|
1,208 |
936 |
$1.23M |
| 93017 |
|
3,911 |
3,489 |
$1.23M |
| 71046 |
Radiologic examination, chest; 2 views |
18,952 |
15,105 |
$1.12M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
25,426 |
7,761 |
$1.11M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
26,356 |
8,183 |
$1.10M |
| J7030 |
Infusion, normal saline solution , 1000 cc |
48,600 |
28,105 |
$1.05M |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
24,559 |
21,113 |
$1.03M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,845 |
4,792 |
$1.01M |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,478 |
2,223 |
$1.01M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
9,957 |
5,296 |
$984K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
136,334 |
104,123 |
$926K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17,981 |
14,922 |
$921K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,670 |
2,347 |
$916K |
| 71250 |
|
6,387 |
4,753 |
$908K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
11,122 |
8,776 |
$865K |
| 72141 |
|
2,763 |
2,278 |
$865K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
17,065 |
9,932 |
$856K |
| 73630 |
|
12,012 |
9,653 |
$837K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
17,897 |
13,475 |
$833K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
6,879 |
5,240 |
$825K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,401 |
1,090 |
$785K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
2,131 |
1,715 |
$775K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
7,139 |
2,871 |
$770K |
| 76830 |
Ultrasound, transvaginal |
6,142 |
5,264 |
$755K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
22,033 |
5,305 |
$726K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
1,117 |
1,072 |
$718K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
1,123 |
1,012 |
$680K |
| 93971 |
|
3,502 |
3,010 |
$658K |
| 73610 |
|
8,378 |
6,682 |
$656K |
| 84443 |
Thyroid stimulating hormone (TSH) |
46,095 |
41,660 |
$655K |
| 72128 |
|
3,909 |
3,171 |
$654K |
| 73560 |
|
10,580 |
7,448 |
$642K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,722 |
10,681 |
$632K |
| 76770 |
|
3,036 |
2,555 |
$628K |
| 93454 |
|
834 |
331 |
$602K |
| 73030 |
|
8,487 |
6,376 |
$585K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
18,267 |
16,772 |
$581K |
| 73221 |
|
1,492 |
1,304 |
$567K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,406 |
1,631 |
$561K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,890 |
8,066 |
$558K |
| 93225 |
|
2,201 |
1,913 |
$537K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,007 |
1,884 |
$533K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,583 |
1,843 |
$530K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16,616 |
7,708 |
$525K |
| 73130 |
|
7,061 |
5,793 |
$524K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,161 |
10,895 |
$520K |
| 93970 |
|
2,655 |
2,331 |
$502K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,973 |
3,929 |
$485K |
| 76536 |
|
4,624 |
4,225 |
$480K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,869 |
1,648 |
$478K |
| 94760 |
|
87,777 |
72,935 |
$466K |
| 70486 |
|
1,996 |
1,650 |
$460K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,420 |
996 |
$453K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
564 |
336 |
$446K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
8,842 |
7,851 |
$441K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
18,942 |
17,227 |
$440K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,516 |
4,871 |
$437K |
| 71270 |
|
1,957 |
1,062 |
$437K |
| 73562 |
|
5,336 |
4,448 |
$418K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,954 |
6,272 |
$405K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,163 |
871 |
$399K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,020 |
706 |
$399K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
50,653 |
36,878 |
$399K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,076 |
915 |
$380K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
4,411 |
3,858 |
$373K |
| 80061 |
Lipid panel |
33,274 |
27,615 |
$361K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
30,961 |
23,068 |
$346K |
| 84484 |
|
28,142 |
19,409 |
$339K |
| 73110 |
|
5,217 |
4,010 |
$338K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,564 |
3,529 |
$325K |
| 70498 |
|
1,019 |
757 |
$322K |
| 94726 |
|
2,035 |
1,747 |
$298K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
7,684 |
7,069 |
$293K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
987 |
854 |
$287K |
| 82607 |
|
22,009 |
20,179 |
$282K |
| J7050 |
Infusion, normal saline solution, 250 cc |
19,345 |
8,597 |
$274K |
| C1776 |
Joint device (implantable) |
434 |
263 |
$274K |
| 72100 |
|
4,346 |
3,763 |
$271K |
| 70496 |
|
906 |
650 |
$265K |
| 87902 |
|
1,305 |
1,066 |
$265K |
| 83880 |
|
9,725 |
6,956 |
$246K |
| 70492 |
|
639 |
465 |
$245K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,314 |
471 |
$243K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
32,888 |
27,315 |
$242K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
9,753 |
8,437 |
$239K |
| 87581 |
|
7,361 |
6,605 |
$237K |
| 87486 |
|
7,663 |
6,659 |
$223K |
| 93922 |
|
1,643 |
1,311 |
$222K |
| 93226 |
|
1,677 |
1,538 |
$222K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,616 |
905 |
$220K |
| 85027 |
|
40,547 |
28,854 |
$220K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27,940 |
25,118 |
$218K |
| 80074 |
|
6,761 |
6,071 |
$215K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,989 |
2,716 |
$214K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,285 |
1,672 |
$214K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,953 |
2,625 |
$209K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
10,096 |
7,980 |
$208K |
| 88304 |
|
4,455 |
3,822 |
$207K |
| 86235 |
|
3,828 |
2,981 |
$200K |
| J2704 |
Injection, propofol, 10 mg |
23,644 |
19,695 |
$194K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17,707 |
16,585 |
$188K |
| 73590 |
|
3,034 |
2,393 |
$186K |
| 95811 |
|
440 |
403 |
$186K |
| 81001 |
|
59,254 |
49,598 |
$183K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
5,636 |
1,799 |
$179K |
| 96415 |
|
1,295 |
840 |
$177K |
| 73700 |
|
1,177 |
857 |
$177K |
| 72170 |
|
3,419 |
2,538 |
$175K |
| J3490 |
Unclassified drugs |
9,649 |
4,642 |
$167K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
12,641 |
7,439 |
$167K |
| 74183 |
|
568 |
419 |
$167K |
| 74018 |
|
2,960 |
2,544 |
$165K |
| 10060 |
|
1,023 |
876 |
$164K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,081 |
5,886 |
$160K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
7,009 |
6,613 |
$159K |
| 84145 |
|
8,387 |
6,289 |
$157K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
5,766 |
1,501 |
$156K |
| 97153 |
Adaptive behavior treatment by protocol, administered by technician, each 15 minutes |
3,923 |
333 |
$155K |
| 73090 |
|
2,438 |
1,919 |
$152K |
| 83605 |
|
16,811 |
12,300 |
$152K |
| 84702 |
|
11,204 |
8,308 |
$151K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,034 |
2,449 |
$148K |
| 76942 |
|
2,586 |
2,016 |
$147K |
| 93880 |
|
2,409 |
1,976 |
$146K |
| 87522 |
Neg quan hep c or qual rna |
3,624 |
3,320 |
$146K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,827 |
4,464 |
$145K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,884 |
4,468 |
$144K |
| 83690 |
|
22,365 |
18,804 |
$144K |
| 73080 |
|
1,892 |
1,573 |
$141K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
7,019 |
6,359 |
$141K |
| 72070 |
|
1,831 |
1,465 |
$138K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
241 |
218 |
$137K |
| 52000 |
|
766 |
584 |
$136K |
| 82652 |
|
4,632 |
4,244 |
$134K |
| 80047 |
|
11,566 |
9,964 |
$132K |
| 72040 |
|
2,216 |
1,801 |
$131K |
| 83516 |
|
4,152 |
3,286 |
$128K |
| 87507 |
|
477 |
418 |
$126K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,568 |
3,994 |
$125K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
6,378 |
2,598 |
$124K |
| 82805 |
|
2,303 |
1,824 |
$123K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
269 |
246 |
$122K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
27,666 |
21,171 |
$121K |
| C1769 |
Guide wire |
4,207 |
3,247 |
$119K |
| 11045 |
|
374 |
224 |
$117K |
| 77080 |
|
1,231 |
951 |
$115K |
| 96367 |
|
10,299 |
2,707 |
$114K |
| 72158 |
|
262 |
212 |
$114K |
| 77066 |
Tomosynthesis, mammo |
2,303 |
1,848 |
$114K |
| 77386 |
|
604 |
43 |
$109K |
| 84703 |
|
16,000 |
13,951 |
$109K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12,229 |
7,245 |
$107K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
28,413 |
23,884 |
$107K |
| 82962 |
|
16,154 |
6,785 |
$106K |
| 83735 |
|
19,609 |
12,259 |
$106K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
26 |
25 |
$105K |
| 72146 |
|
348 |
288 |
$105K |
| 94729 |
|
1,897 |
1,706 |
$103K |
| 84439 |
|
12,921 |
11,769 |
$102K |
| 36592 |
|
6,607 |
1,905 |
$102K |
| 80081 |
|
1,702 |
1,547 |
$100K |
| 36600 |
|
3,699 |
2,609 |
$100K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
267 |
254 |
$98K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
4,791 |
4,358 |
$98K |
| 84144 |
|
5,122 |
4,345 |
$98K |
| 73502 |
|
6,986 |
4,981 |
$98K |
| 78227 |
|
327 |
273 |
$97K |
| 64415 |
|
662 |
415 |
$97K |
| 87040 |
|
7,732 |
5,148 |
$96K |
| 11043 |
|
753 |
461 |
$94K |
| 82728 |
|
8,078 |
7,080 |
$94K |
| 64447 |
|
813 |
557 |
$94K |
| 83520 |
|
4,229 |
3,408 |
$94K |
| J1644 |
Injection, heparin sodium, per 1000 units |
15,228 |
5,235 |
$93K |
| 87077 |
|
13,160 |
9,332 |
$92K |
| 82746 |
|
7,447 |
6,791 |
$92K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,239 |
2,786 |
$91K |
| 76642 |
|
2,251 |
1,990 |
$90K |
| 86850 |
|
9,114 |
7,556 |
$90K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
24,657 |
20,176 |
$90K |
| 77336 |
|
1,236 |
310 |
$89K |
| 94010 |
|
1,957 |
1,372 |
$88K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
6,106 |
5,164 |
$88K |
| 85610 |
|
22,420 |
16,467 |
$87K |
| 86140 |
|
19,226 |
15,666 |
$85K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28,819 |
21,685 |
$84K |
| 84403 |
|
3,806 |
3,503 |
$83K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,157 |
632 |
$83K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
12,121 |
7,781 |
$83K |
| 95816 |
|
981 |
889 |
$82K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
3,568 |
2,348 |
$82K |
| 0002A |
|
4,992 |
4,834 |
$81K |
| 80050 |
General health panel |
2,316 |
1,742 |
$80K |
| 69210 |
|
1,836 |
1,395 |
$80K |
| 97162 |
|
5,072 |
2,910 |
$79K |
| 93458 |
|
37 |
27 |
$79K |
| 73100 |
|
1,333 |
1,042 |
$77K |
| 83970 |
|
2,454 |
2,156 |
$77K |
| 84425 |
|
4,241 |
3,874 |
$75K |
| 83540 |
|
13,878 |
11,582 |
$75K |
| J1756 |
Injection, iron sucrose, 1 mg |
477 |
174 |
$75K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
42,210 |
30,896 |
$75K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,663 |
2,239 |
$74K |
| 87070 |
|
8,011 |
4,948 |
$74K |
| 80076 |
|
9,940 |
8,507 |
$73K |
| 97597 |
|
1,416 |
992 |
$73K |
| 87186 |
|
9,445 |
7,939 |
$73K |
| 95909 |
|
822 |
753 |
$72K |
| 81025 |
|
9,505 |
8,348 |
$72K |
| 29125 |
|
886 |
786 |
$72K |
| 86038 |
|
6,959 |
6,250 |
$71K |
| 99218 |
|
548 |
399 |
$71K |
| 81003 |
|
22,942 |
16,446 |
$71K |
| 97803 |
|
4,836 |
4,228 |
$71K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
535 |
496 |
$70K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
28,450 |
20,767 |
$70K |
| G0379 |
Direct admission of patient for hospital observation care |
1,769 |
1,258 |
$70K |
| 87430 |
|
4,564 |
4,262 |
$68K |
| 51702 |
|
1,498 |
919 |
$68K |
| 87634 |
|
1,095 |
1,035 |
$67K |
| 94060 |
|
859 |
533 |
$67K |
| 82105 |
|
4,024 |
3,643 |
$67K |
| 78306 |
|
479 |
239 |
$66K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,806 |
2,178 |
$65K |
| 85730 |
|
13,336 |
9,796 |
$62K |
| 88342 |
|
1,412 |
1,105 |
$61K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12,413 |
8,020 |
$61K |
| 76000 |
|
1,163 |
810 |
$61K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
7,317 |
6,346 |
$61K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
403 |
373 |
$60K |
| 78264 |
|
255 |
202 |
$58K |
| 97010 |
|
3,375 |
919 |
$58K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,420 |
2,081 |
$57K |
| 84207 |
|
2,392 |
2,162 |
$57K |
| 0001A |
|
5,142 |
4,927 |
$57K |
| 93923 |
|
602 |
474 |
$55K |
| 31575 |
|
1,184 |
932 |
$54K |
| 86160 |
|
3,677 |
2,856 |
$54K |
| 86480 |
|
1,087 |
1,001 |
$53K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,465 |
993 |
$53K |
| 73060 |
|
922 |
722 |
$53K |
| 74022 |
|
551 |
480 |
$53K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,380 |
1,139 |
$51K |
| 20551 |
|
726 |
516 |
$51K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,056 |
1,006 |
$51K |
| 76870 |
|
823 |
725 |
$50K |
| 72110 |
|
500 |
423 |
$50K |
| 99292 |
|
78 |
66 |
$50K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
457 |
310 |
$50K |
| 83001 |
|
2,639 |
2,388 |
$48K |
| 93925 |
|
436 |
387 |
$48K |
| 80305 |
|
6,394 |
4,956 |
$48K |
| 86147 |
|
1,100 |
808 |
$47K |
| 84134 |
|
3,775 |
3,448 |
$47K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,354 |
1,107 |
$47K |
| 86256 |
|
3,179 |
2,771 |
$46K |
| 87481 |
|
921 |
770 |
$46K |
| 84480 |
|
3,947 |
3,691 |
$45K |
| 90715 |
|
3,757 |
3,465 |
$45K |
| 82150 |
|
7,150 |
6,267 |
$45K |
| 73070 |
|
719 |
553 |
$45K |
| 86901 |
|
7,821 |
6,267 |
$45K |
| 0353U |
|
1,836 |
1,420 |
$44K |
| 95806 |
|
758 |
591 |
$44K |
| C9113 |
Injection, pantoprazole sodium, per vial |
5,253 |
2,239 |
$44K |
| 11721 |
|
1,316 |
1,027 |
$43K |
| J0248 |
Injection, remdesivir, 1 mg |
165 |
60 |
$43K |
| 85652 |
|
15,687 |
13,292 |
$43K |
| 82677 |
|
1,884 |
1,782 |
$43K |
| 86376 |
|
3,368 |
3,087 |
$42K |
| 92526 |
|
658 |
337 |
$41K |
| 73120 |
|
645 |
538 |
$41K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
7,451 |
7,147 |
$41K |
| 87899 |
|
1,439 |
1,207 |
$41K |
| 84436 |
|
6,942 |
6,433 |
$41K |
| 27447 |
|
141 |
25 |
$41K |
| 83002 |
|
2,502 |
2,302 |
$41K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,837 |
1,764 |
$40K |
| 77065 |
Tomosynthesis, mammo |
1,655 |
1,270 |
$40K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,371 |
1,845 |
$40K |
| 10005 |
|
206 |
171 |
$40K |
| 82803 |
|
2,274 |
1,706 |
$39K |
| J1953 |
Injection, levetiracetam, 10 mg |
533 |
301 |
$39K |
| 82550 |
|
5,221 |
4,078 |
$39K |
| 84466 |
|
4,104 |
3,543 |
$39K |
| 86900 |
|
7,761 |
6,255 |
$39K |
| 85379 |
|
4,505 |
3,757 |
$37K |
| 93296 |
|
4,430 |
4,040 |
$37K |
| 87340 |
|
4,642 |
4,154 |
$37K |
| 12001 |
|
715 |
547 |
$37K |
| 58300 |
|
536 |
498 |
$37K |
| 82784 |
|
3,641 |
2,876 |
$36K |
| 86762 |
|
3,197 |
2,869 |
$36K |
| 97116 |
|
1,874 |
604 |
$36K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,805 |
1,635 |
$35K |
| 49083 |
|
237 |
97 |
$34K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,009 |
2,748 |
$34K |
| 92523 |
|
543 |
459 |
$34K |
| 97166 |
|
1,941 |
1,545 |
$34K |
| 86200 |
|
3,474 |
2,987 |
$34K |
| 20550 |
|
250 |
225 |
$33K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
5,681 |
4,885 |
$32K |
| 84153 |
|
2,372 |
2,093 |
$32K |
| 87081 |
|
3,569 |
3,274 |
$32K |
| 86255 |
|
2,487 |
2,159 |
$31K |
| 73552 |
|
1,809 |
1,400 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,033 |
1,872 |
$30K |
| 43235 |
|
108 |
82 |
$30K |
| 86803 |
|
2,616 |
2,377 |
$30K |
| 95886 |
|
929 |
769 |
$29K |
| 73140 |
|
1,158 |
905 |
$29K |
| G0390 |
Trauma response team associated with hospital critical care service |
43 |
39 |
$29K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
2,003 |
1,778 |
$28K |
| 82239 |
|
1,897 |
1,450 |
$28K |
| 81002 |
|
8,562 |
6,265 |
$28K |
| J0875 |
Injection, dalbavancin, 5 mg |
12 |
12 |
$28K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
102 |
72 |
$28K |
| 83615 |
|
4,949 |
3,634 |
$28K |
| 98926 |
|
1,739 |
1,499 |
$27K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
840 |
388 |
$27K |
| 86336 |
|
1,877 |
1,778 |
$27K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,643 |
1,220 |
$27K |
| 86146 |
|
858 |
723 |
$26K |
| 84146 |
|
1,551 |
1,422 |
$26K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
371 |
322 |
$25K |
| 81514 |
|
381 |
307 |
$25K |
| 86709 |
|
2,993 |
2,602 |
$25K |
| 36430 |
|
166 |
95 |
$25K |
| J7070 |
Infusion, d5w, 1000 cc |
1,176 |
569 |
$25K |
| 73564 |
|
257 |
226 |
$25K |
| 86225 |
|
2,467 |
2,124 |
$25K |
| 52352 |
|
41 |
26 |
$25K |
| 86320 |
|
1,026 |
914 |
$25K |
| 84550 |
|
6,099 |
4,943 |
$25K |
| 82330 |
|
2,330 |
1,473 |
$25K |
| 86708 |
|
2,015 |
1,852 |
$25K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
205 |
81 |
$24K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,864 |
1,010 |
$24K |
| 84100 |
|
6,382 |
3,912 |
$24K |
| 88307 |
|
435 |
318 |
$24K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,195 |
1,218 |
$24K |
| 73600 |
|
434 |
352 |
$24K |
| 93308 |
|
290 |
240 |
$23K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
3,093 |
2,455 |
$23K |
| 29824 |
|
115 |
96 |
$23K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,332 |
1,510 |
$23K |
| 82378 |
|
1,415 |
1,043 |
$23K |
| 73620 |
|
334 |
299 |
$23K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
1,339 |
941 |
$23K |
| 82172 |
|
1,303 |
1,107 |
$23K |
| 83883 |
|
1,589 |
1,421 |
$23K |
| 86704 |
|
2,026 |
1,883 |
$23K |
| 73521 |
|
905 |
708 |
$22K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
809 |
682 |
$22K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
5,425 |
3,420 |
$22K |
| 77300 |
|
99 |
44 |
$22K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
420 |
194 |
$22K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,609 |
1,003 |
$21K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
955 |
505 |
$21K |
| 84481 |
|
1,556 |
1,414 |
$21K |
| Q3014 |
Telehealth originating site facility fee |
5,708 |
4,924 |
$21K |
| 76857 |
|
142 |
121 |
$21K |
| J1956 |
Injection, levofloxacin, 250 mg |
1,089 |
573 |
$20K |
| 98927 |
|
1,268 |
1,102 |
$20K |
| 29881 |
|
73 |
56 |
$20K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
4,348 |
2,930 |
$20K |
| 72157 |
|
54 |
41 |
$20K |
| 86706 |
|
1,788 |
1,637 |
$19K |
| 82140 |
|
1,831 |
1,274 |
$19K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
91 |
89 |
$19K |
| 74220 |
|
139 |
127 |
$19K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
600 |
514 |
$19K |
| 86592 |
|
4,701 |
4,173 |
$19K |
| 86618 |
|
791 |
698 |
$19K |
| 96417 |
|
780 |
451 |
$19K |
| 87493 |
|
619 |
516 |
$19K |
| 64615 |
|
177 |
161 |
$18K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
3,561 |
2,883 |
$18K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
5,761 |
5,105 |
$18K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
2,308 |
2,076 |
$18K |
| 82085 |
|
1,336 |
1,168 |
$17K |
| 83655 |
|
1,467 |
1,406 |
$17K |
| 72202 |
|
288 |
276 |
$17K |
| 84402 |
|
862 |
771 |
$16K |
| 97155 |
Adaptive behavior treatment with protocol modification, administered by physician, each 15 minutes |
1,186 |
321 |
$16K |
| 97161 |
|
779 |
650 |
$16K |
| 86334 |
|
1,060 |
966 |
$16K |
| 82951 |
|
1,278 |
1,091 |
$16K |
| 74174 |
|
125 |
100 |
$16K |
| 82248 |
|
3,421 |
2,863 |
$16K |
| 96523 |
|
2,233 |
593 |
$16K |
| 29879 |
|
53 |
40 |
$16K |
| 83010 |
|
1,304 |
1,208 |
$16K |
| 92557 |
|
367 |
321 |
$16K |
| 72050 |
|
167 |
139 |
$16K |
| 29425 |
|
280 |
236 |
$16K |
| 84156 |
|
3,931 |
2,988 |
$15K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
88 |
83 |
$15K |
| 83550 |
|
2,256 |
2,052 |
$15K |
| 86317 |
|
1,303 |
1,157 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
658 |
476 |
$15K |
| V2632 |
Posterior chamber intraocular lens |
507 |
366 |
$15K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,540 |
3,534 |
$14K |
| 82565 |
|
3,858 |
3,119 |
$14K |
| 70491 |
|
57 |
43 |
$14K |
| 81374 |
|
204 |
157 |
$14K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
13,894 |
10,370 |
$14K |
| 82747 |
|
923 |
857 |
$14K |
| 71271 |
|
662 |
526 |
$14K |
| 85007 |
|
4,257 |
3,402 |
$13K |
| 87807 |
|
1,048 |
990 |
$13K |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
504 |
315 |
$13K |
| 11055 |
|
303 |
227 |
$13K |
| 12002 |
|
149 |
130 |
$13K |
| 77334 |
|
47 |
27 |
$12K |
| 74240 |
|
106 |
93 |
$12K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
555 |
335 |
$12K |
| 82360 |
|
765 |
637 |
$12K |
| 86430 |
|
2,385 |
2,180 |
$12K |
| 77002 |
|
252 |
175 |
$12K |
| 82043 |
|
2,361 |
2,116 |
$12K |
| 97802 |
|
502 |
459 |
$12K |
| 88312 |
|
814 |
682 |
$12K |
| J0184 |
Injection, amisulpride, 1 mg |
119 |
93 |
$12K |
| 87075 |
|
1,212 |
919 |
$12K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
1,806 |
1,018 |
$11K |
| 90746 |
|
625 |
567 |
$11K |
| 82950 |
|
2,779 |
2,438 |
$11K |
| 72156 |
|
35 |
29 |
$11K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
71 |
28 |
$11K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
693 |
488 |
$11K |
| 82977 |
|
1,446 |
1,324 |
$11K |
| 87045 |
|
1,237 |
986 |
$11K |
| 80069 |
|
1,204 |
971 |
$11K |
| 42821 |
|
16 |
14 |
$10K |
| 84165 |
|
1,277 |
1,130 |
$10K |
| 96130 |
|
183 |
177 |
$10K |
| 73702 |
|
53 |
28 |
$10K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
29 |
26 |
$10K |
| 97804 |
|
1,064 |
931 |
$10K |
| 84132 |
|
2,348 |
1,810 |
$10K |
| 80177 |
|
725 |
667 |
$9K |
| 92567 |
|
577 |
547 |
$9K |
| 76882 |
|
156 |
143 |
$9K |
| 82103 |
|
788 |
689 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
256 |
241 |
$9K |
| 86431 |
|
2,156 |
1,749 |
$9K |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
323 |
312 |
$9K |
| 90686 |
|
2,753 |
2,530 |
$9K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
131 |
81 |
$8K |
| 87209 |
|
520 |
454 |
$8K |
| 93270 |
|
621 |
557 |
$8K |
| 82570 |
|
1,821 |
1,533 |
$8K |
| 95249 |
|
500 |
467 |
$8K |
| 11750 |
|
41 |
32 |
$8K |
| 96131 |
|
182 |
176 |
$8K |
| 81596 |
|
292 |
245 |
$8K |
| 90670 |
|
3,072 |
2,941 |
$8K |
| 86308 |
|
1,545 |
1,420 |
$8K |
| 87800 |
|
297 |
260 |
$8K |
| 90714 |
|
208 |
194 |
$8K |
| 75635 |
|
48 |
29 |
$8K |
| 83874 |
|
331 |
219 |
$8K |
| 29880 |
|
31 |
28 |
$8K |
| 73200 |
|
27 |
24 |
$8K |
| 93312 |
|
17 |
12 |
$8K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
429 |
408 |
$8K |
| 0004A |
|
1,046 |
985 |
$7K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
162 |
154 |
$7K |
| 90633 |
|
2,066 |
2,001 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
514 |
449 |
$7K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
12 |
12 |
$7K |
| 82731 |
|
106 |
101 |
$7K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,132 |
682 |
$7K |
| 90474 |
|
2,851 |
2,747 |
$7K |
| 92083 |
|
270 |
244 |
$7K |
| 82553 |
|
352 |
246 |
$7K |
| 86665 |
|
209 |
184 |
$7K |
| 76801 |
|
155 |
133 |
$6K |
| J1630 |
Injection, haloperidol, up to 5 mg |
819 |
662 |
$6K |
| J1815 |
Injection, insulin, per 5 units |
224 |
120 |
$6K |
| 85018 |
|
2,838 |
2,273 |
$6K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
491 |
373 |
$6K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
19 |
17 |
$6K |
| 93298 |
|
643 |
609 |
$6K |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
602 |
126 |
$6K |
| 80202 |
|
704 |
346 |
$6K |
| 64445 |
|
52 |
28 |
$6K |
| 82390 |
|
646 |
579 |
$6K |
| 82947 |
|
1,670 |
1,119 |
$5K |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
730 |
275 |
$5K |
| 86705 |
|
474 |
435 |
$5K |
| 86920 |
|
144 |
97 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
1,705 |
1,269 |
$5K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
55 |
53 |
$5K |
| 76519 |
|
311 |
202 |
$5K |
| 85045 |
|
1,500 |
1,363 |
$5K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
286 |
235 |
$5K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
28 |
24 |
$5K |
| 83993 |
|
275 |
242 |
$5K |
| 29826 |
|
127 |
108 |
$5K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
263 |
246 |
$5K |
| 83527 |
|
439 |
413 |
$5K |
| 97035 |
|
148 |
44 |
$5K |
| 72082 |
|
133 |
127 |
$5K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,210 |
485 |
$5K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,362 |
719 |
$5K |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
206 |
53 |
$4K |
| J3360 |
Injection, diazepam, up to 5 mg |
243 |
140 |
$4K |
| 87177 |
|
540 |
469 |
$4K |
| 87538 |
|
174 |
158 |
$4K |
| 87205 |
|
1,357 |
1,096 |
$4K |
| 90688 |
|
1,442 |
1,382 |
$4K |
| 17110 |
|
67 |
59 |
$4K |
| 96368 |
|
321 |
170 |
$4K |
| 98925 |
|
265 |
236 |
$4K |
| 36416 |
|
2,496 |
839 |
$4K |
| 83921 |
|
303 |
271 |
$4K |
| 99152 |
|
129 |
107 |
$4K |
| L4387 |
Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf |
200 |
134 |
$4K |
| 87535 |
|
172 |
156 |
$4K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
103 |
42 |
$4K |
| 83525 |
|
401 |
381 |
$4K |
| 84450 |
|
1,001 |
861 |
$4K |
| 82787 |
|
658 |
566 |
$4K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
126 |
69 |
$4K |
| 84460 |
|
953 |
814 |
$4K |
| A4565 |
Slings |
1,760 |
1,314 |
$4K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
114 |
90 |
$4K |
| 29515 |
|
49 |
42 |
$4K |
| 93299 |
|
364 |
344 |
$4K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
100 |
96 |
$4K |
| 77280 |
|
106 |
12 |
$4K |
| 11102 |
|
61 |
51 |
$4K |
| 94667 |
|
165 |
120 |
$4K |
| 57500 |
|
13 |
13 |
$4K |
| J1940 |
Injection, furosemide, up to 20 mg |
879 |
357 |
$4K |
| 93280 |
|
548 |
312 |
$4K |
| 87517 |
|
96 |
90 |
$3K |
| 97151 |
|
253 |
101 |
$3K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
13 |
12 |
$3K |
| 84295 |
|
434 |
333 |
$3K |
| A9561 |
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries |
34 |
28 |
$3K |
| C1758 |
Catheter, ureteral |
306 |
263 |
$3K |
| 11056 |
|
125 |
76 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,586 |
1,251 |
$3K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
98 |
68 |
$3K |
| 90632 |
|
303 |
279 |
$3K |
| 76775 |
|
63 |
40 |
$3K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
32 |
30 |
$3K |
| 73000 |
|
78 |
53 |
$3K |
| 88313 |
|
158 |
130 |
$3K |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
1,144 |
974 |
$3K |
| 88341 |
|
81 |
64 |
$3K |
| 0012A |
|
216 |
209 |
$3K |
| 29876 |
|
40 |
27 |
$3K |
| 86580 |
|
367 |
314 |
$3K |
| C2618 |
Probe/needle, cryoablation |
118 |
36 |
$3K |
| 58100 |
|
14 |
14 |
$3K |
| 90680 |
|
2,677 |
2,598 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
151 |
122 |
$2K |
| 86617 |
|
220 |
187 |
$2K |
| 75574 |
|
15 |
15 |
$2K |
| 12011 |
|
39 |
38 |
$2K |
| 29130 |
|
55 |
51 |
$2K |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
141 |
122 |
$2K |
| 86300 |
|
141 |
80 |
$2K |
| 82247 |
|
488 |
331 |
$2K |
| 95819 |
|
48 |
37 |
$2K |
| 90677 |
|
627 |
617 |
$2K |
| 82533 |
|
147 |
132 |
$2K |
| 82164 |
|
70 |
67 |
$2K |
| 71101 |
|
32 |
29 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
109 |
61 |
$2K |
| 82785 |
|
86 |
79 |
$2K |
| 85014 |
|
1,136 |
798 |
$2K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
151 |
132 |
$2K |
| 85384 |
|
244 |
184 |
$2K |
| 84445 |
|
42 |
40 |
$2K |
| 90647 |
|
2,969 |
2,865 |
$2K |
| 94668 |
|
35 |
16 |
$2K |
| 86703 |
|
178 |
155 |
$2K |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
150 |
131 |
$2K |
| 25600 |
|
14 |
14 |
$2K |
| 29075 |
|
27 |
25 |
$2K |
| 90700 |
|
552 |
536 |
$2K |
| 51798 |
|
53 |
39 |
$2K |
| 97163 |
|
250 |
66 |
$2K |
| 90832 |
Psychotherapy, 30 minutes with patient |
69 |
61 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
965 |
368 |
$2K |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
113 |
106 |
$1K |
| 84479 |
|
386 |
364 |
$1K |
| 90723 |
|
3,023 |
2,925 |
$1K |
| 90649 |
|
138 |
132 |
$1K |
| 97156 |
|
156 |
132 |
$1K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
50 |
49 |
$1K |
| 58301 |
|
14 |
14 |
$1K |
| 0011A |
|
191 |
177 |
$1K |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
208 |
70 |
$1K |
| 72072 |
|
12 |
12 |
$1K |
| 93291 |
|
102 |
70 |
$1K |
| 86664 |
|
86 |
80 |
$1K |
| 84432 |
|
80 |
68 |
$1K |
| 80171 |
|
57 |
53 |
$1K |
| 94664 |
|
73 |
57 |
$1K |
| 82010 |
|
195 |
135 |
$1K |
| 84630 |
|
130 |
113 |
$1K |
| 86663 |
|
84 |
78 |
$1K |
| 82272 |
|
327 |
268 |
$983.94 |
| 85732 |
|
252 |
215 |
$982.30 |
| 0003A |
|
118 |
110 |
$939.63 |
| 76937 |
|
145 |
108 |
$928.14 |
| 82525 |
|
95 |
87 |
$917.03 |
| A4649 |
Surgical supply; miscellaneous |
366 |
263 |
$910.50 |
| 86738 |
|
55 |
51 |
$907.80 |
| G0010 |
Administration of hepatitis b vaccine |
46 |
39 |
$903.36 |
| 0071A |
|
135 |
118 |
$888.41 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
25 |
25 |
$885.69 |
| 76641 |
|
12 |
12 |
$885.18 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
163 |
122 |
$852.61 |
| 87329 |
|
74 |
67 |
$837.65 |
| 90707 |
|
395 |
381 |
$821.88 |
| 94761 |
|
109 |
51 |
$820.37 |
| 0072A |
|
109 |
104 |
$797.48 |
| 80323 |
|
31 |
31 |
$784.46 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
34 |
29 |
$781.76 |
| 94618 |
|
41 |
30 |
$777.20 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
190 |
96 |
$775.42 |
| 97018 |
|
37 |
12 |
$775.00 |
| 99219 |
|
43 |
35 |
$766.59 |
| 86769 |
|
19 |
18 |
$736.38 |
| 93271 |
|
15 |
13 |
$707.67 |
| 87449 |
|
68 |
52 |
$651.84 |
| 98928 |
|
30 |
26 |
$642.06 |
| C1729 |
Catheter, drainage |
56 |
37 |
$609.56 |
| 86800 |
|
49 |
44 |
$603.13 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
40 |
33 |
$602.02 |
| A9270 |
Non-covered item or service |
6,264 |
1,233 |
$593.19 |
| 82009 |
|
124 |
100 |
$588.95 |
| 86304 |
|
42 |
28 |
$564.27 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
40 |
25 |
$527.12 |
| 90734 |
|
363 |
356 |
$494.70 |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
16 |
16 |
$494.47 |
| J3411 |
Injection, thiamine hcl, 100 mg |
64 |
27 |
$462.96 |
| 92136 |
|
16 |
15 |
$453.39 |
| 81015 |
|
1,017 |
924 |
$449.85 |
| 80164 |
|
38 |
36 |
$447.65 |
| 82552 |
|
40 |
36 |
$445.92 |
| 90716 |
|
344 |
329 |
$420.20 |
| G0008 |
Administration of influenza virus vaccine |
62 |
47 |
$411.06 |
| 90671 |
|
244 |
241 |
$395.75 |
| 90710 |
|
593 |
574 |
$358.45 |
| 84446 |
|
29 |
28 |
$351.42 |
| 86682 |
|
41 |
37 |
$349.45 |
| 97167 |
|
36 |
28 |
$347.14 |
| 83825 |
|
29 |
26 |
$345.13 |
| 82040 |
|
223 |
190 |
$344.76 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
963 |
618 |
$332.86 |
| 90658 |
|
139 |
134 |
$331.67 |
| 82175 |
|
29 |
26 |
$326.73 |
| 87210 |
|
60 |
56 |
$326.34 |
| 90651 |
|
121 |
119 |
$323.19 |
| 82948 |
|
172 |
112 |
$321.80 |
| 82670 |
|
13 |
12 |
$311.26 |
| 36591 |
|
39 |
14 |
$282.02 |
| 86301 |
|
17 |
12 |
$270.13 |
| 84520 |
|
133 |
96 |
$265.70 |
| 90655 |
|
106 |
104 |
$264.85 |
| 82705 |
|
72 |
45 |
$256.37 |
| 90685 |
|
662 |
629 |
$252.52 |
| 85300 |
|
36 |
27 |
$235.38 |
| 82435 |
|
32 |
27 |
$210.97 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
311 |
286 |
$199.92 |
| 97168 |
|
15 |
12 |
$191.22 |
| 84155 |
|
109 |
95 |
$188.33 |
| 84442 |
|
14 |
12 |
$177.38 |
| 87425 |
|
13 |
12 |
$170.09 |
| 82952 |
|
84 |
75 |
$158.21 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
43 |
36 |
$153.87 |
| 84590 |
|
13 |
13 |
$150.69 |
| 86593 |
|
39 |
36 |
$150.15 |
| 87101 |
|
21 |
16 |
$149.28 |
| 80185 |
|
18 |
12 |
$133.10 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
28 |
25 |
$114.88 |
| 90696 |
|
265 |
257 |
$108.73 |
| 85302 |
|
16 |
12 |
$107.61 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
19 |
13 |
$107.23 |
| 87324 |
|
30 |
26 |
$106.62 |
| J7510 |
Prednisolone oral, per 5 mg |
49 |
24 |
$97.60 |
| 84075 |
|
25 |
25 |
$94.24 |
| 85613 |
|
16 |
14 |
$87.36 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
18 |
16 |
$86.17 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
108 |
40 |
$67.92 |
| 85670 |
|
12 |
12 |
$46.88 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
89 |
72 |
$36.09 |
| 85049 |
|
20 |
15 |
$23.36 |
| 90653 |
|
43 |
22 |
$11.82 |
| 90620 |
|
33 |
33 |
$0.00 |
| 29823 |
|
15 |
12 |
$0.00 |